Researchers create test to identify super bacteria MRSA in record time

May 23, 2013 by Janet Mccoy, Auburn University

A research team has created a test using a biosensor that will help medical professionals more quickly identify super bacteria like MRSA.

can be difficult to diagnose, and quick diagnosis and treatment can mean the difference between life and death, says lead researcher Vitaly Vodyanoy of Auburn University. The biosensor can identify specific bacteria in as little as 10 minutes compared to hours.

Vodyanoy, a professor in Auburn University's College of Veterinary Medicine, said he and his research team created the prototype biosensor as the first step in fighting like MRSA, methicillin-resistant Staphylococcus aureus, a potentially dangerous type of resistant to certain antibiotics, that can cause skin infections and even death.

The disease is of particular concern to hospitals, prisons and the military, where individuals are at risk for infection. Also, data from the show that 12 million doctor visits a year are for suspected staph and MRSA skin infections.

"Though only MRSA were used in this work, it can also be applied to other antibiotic resistant bacteria," said co-author Iryna Sorokulova, a professor of microbiology at Auburn University.

The research, published in the May 8 edition of Journal of Visualized Experiments, JoVE, is a collaborative effort between Vodyanoy, a professor of physiology and director of the Laboratory, and Keesler Air Force Base, with funding from the U.S. Air Force.

"What we have studied to date has been related to laboratory conditions," Vodyanoy said. "We are ready to take the next step in our research, which is clinical studies with people."

According to the published report, Vodyanoy's technology takes advantage of bacteriophages, simple viruses that can target and kill bacteria. A bacteriophage, when combined with specific antibodies, can be used to produce a physical property change in a sample that indicates . literally means "to eat bacteria."

"This lab-produced virus targets staph," Vodyanoy said. "We envision a future where clinicians do tests with real blood or saliva samples. The virus is completely benign to humans, and we hope to use it to make antimicrobial surfaces and glassware that kill the bacteria."

Vodyanoy said the research is complex, and that publishing it in the Journal of Visualized Experiments, a peer reviewed, video format PubMed indexed journal, will help promote recognition and acceptance of the technique.

Explore further: Biosensor that detects antibiotic resistance brings us one step closer to fighting superbugs

Related Stories

Recommended for you

Where is the universe hiding its missing mass?

February 15, 2019

Astronomers have spent decades looking for something that sounds like it would be hard to miss: about a third of the "normal" matter in the Universe. New results from NASA's Chandra X-ray Observatory may have helped them ...

What rising seas mean for local economies

February 15, 2019

Impacts from climate change are not always easy to see. But for many local businesses in coastal communities across the United States, the evidence is right outside their doors—or in their parking lots.

Tiny particles can switch back and forth between phases

February 15, 2019

Three years ago, when Richard Robinson, associate professor of materials science and engineering, was on sabbatical at Hebrew University in Israel, he asked a graduate student to send him some nanoparticles of a specific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.